Skip Nav Destination
Issues
1 July 2009
-
Cover Image
Cover Image
Electrochemical sensor for multiplex salivary biomarker detection. Salivary IL-8 mRNA and IL-8 protein were detected simultaneously on the same array of electrodes. The multiplex assay can discriminate oral cancer from matched control saliva samples. For further details, please see the article by Wei and colleagues on page 4446 of this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Editorial
CCR Translations
Statistics in Clinical Cancer Research
Molecular Pathways
Review
Human Cancer Biology
Collapse of the CD27+ B-Cell Compartment Associated with Systemic Plasmacytosis in Patients with Advanced Melanoma and Other Cancers
Erica L. Carpenter; Rosemarie Mick; Andrew J. Rech; Gregory L. Beatty; Theresa A. Colligon; Myrna R. Rosenfeld; David E. Kaplan; Kyong-Mi Chang; Susan M. Domchek; Peter A. Kanetsky; Leslie A. Fecher; Keith T. Flaherty; Lynn M. Schuchter; Robert H. Vonderheide
Urine Analysis and Protein Networking Identify Met as a Marker of Metastatic Prostate Cancer
Andrea L. Russo; Kimberly Jedlicka; Meredith Wernick; Debbie McNally; Melissa Kirk; Mary Sproull; Sharon Smith; Uma Shankavaram; Aradhana Kaushal; William D. Figg; William Dahut; Deborah Citrin; Donald P. Bottaro; Paul S. Albert; Philip J. Tofilon; Kevin Camphausen
Cells with Characteristics of Cancer Stem/Progenitor Cells Express the CD133 Antigen in Human Endometrial Tumors
Sergio Rutella; Giuseppina Bonanno; Annabella Procoli; Andrea Mariotti; Maria Corallo; Maria Grazia Prisco; Adriana Eramo; Chiara Napoletano; Daniela Gallo; Alessandro Perillo; Marianna Nuti; Luca Pierelli; Ugo Testa; Giovanni Scambia; Gabriella Ferrandina
Cancer Therapy: Preclinical
Antitumor Activity of NK012 Combined with Cisplatin against Small Cell Lung Cancer and Intestinal Mucosal Changes in Tumor-Bearing Mouse after Treatment
Tatsuya Nagano; Masahiro Yasunaga; Koichi Goto; Hirotsugu Kenmotsu; Yoshikatsu Koga; Jun-ichiro Kuroda; Yoshihiro Nishimura; Takashi Sugino; Yutaka Nishiwaki; Yasuhiro Matsumura
Genomic Screening for Genes Silenced by DNA Methylation Revealed an Association between RASD1 Inactivation and Dexamethasone Resistance in Multiple Myeloma
Masanori Nojima; Reo Maruyama; Hiroshi Yasui; Hiromu Suzuki; Yumiko Maruyama; Isao Tarasawa; Yasushi Sasaki; Hideki Asaoku; Hajime Sakai; Toshiaki Hayashi; Mitsuru Mori; Kohzoh Imai; Takashi Tokino; Tadao Ishida; Minoru Toyota; Yasuhisa Shinomura
Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication
Robin J. Prestwich; Elizabeth J. Ilett; Fiona Errington; Rosa M. Diaz; Lynette P. Steele; Tim Kottke; Jill Thompson; Feorillo Galivo; Kevin J. Harrington; Hardev S. Pandha; Peter J. Selby; Richard G. Vile; Alan A. Melcher
Release of HMGB1 in Response to Proapoptotic Glioma Killing Strategies: Efficacy and Neurotoxicity
Marianela Candolfi; Kader Yagiz; David Foulad; Gabrielle E. Alzadeh; Matthew Tesarfreund; A.K.M. Ghulam Muhammad; Mariana Puntel; Kurt M. Kroeger; Chunyan Liu; Sharon Lee; James F. Curtin; Gwendalyn D. King; Jonathan Lerner; Katsuaki Sato; Yohei Mineharu; Weidong Xiong; Pedro R. Lowenstein; Maria G. Castro
Imaging, Diagnosis, Prognosis
Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome
Davide Rossi; Valeria Spina; Michaela Cerri; Silvia Rasi; Clara Deambrogi; Lorenzo De Paoli; Luca Laurenti; Rossana Maffei; Francesco Forconi; Francesco Bertoni; Emanuele Zucca; Claudio Agostinelli; Antonello Cabras; Marco Lucioni; Maurizio Martini; Michele Magni; Silvia Deaglio; Marco Ladetto; Josep F. Nomdedeu; Caroline Besson; Antonio Ramponi; Vincenzo Canzonieri; Marco Paulli; Roberto Marasca; Luigi M. Larocca; Antonino Carbone; Stefano A. Pileri; Valter Gattei; Gianluca Gaidano
Proposal and Validation of Prognostic Scoring Systems for IgG and IgA Monoclonal Gammopathies of Undetermined Significance
Francesca Rossi; Maria Teresa Petrucci; Andrea Guffanti; Luigi Marcheselli; Davide Rossi; Vincenzo Callea; Federico Vincenzo; Marianna De Muro; Alessandra Baraldi; Oreste Villani; Pellegrino Musto; Andrea Bacigalupo; Gianluca Gaidano; Giuseppe Avvisati; Maria Goldaniga; Lorenzo DePaoli; Luca Baldini
Cancer Therapy: Clinical
Phase I Pharmacokinetic and Pharmacodynamic Study of Carboplatin and Topotecan Administered Intravenously Every 28 Days to Patients with Malignant Solid Tumors
David S. Boss; Wandena S. Siegel-Lakhai; Nadja E. van Egmond-Schoemaker; Dick Pluim; Hilde Rosing; Wim W. ten Bokkel Huinink; Jos H. Beijnen; Jan H.M. Schellens
A Phase I Trial of Radioimmunotherapy with 131I-A5B7 Anti-CEA Antibody in Combination with Combretastatin-A4-Phosphate in Advanced Gastrointestinal Carcinomas
Tim Meyer; Andrew M. Gaya; Gairin Dancey; Michael R.L. Stratford; Shokri Othman; Surinder K. Sharma; David Wellsted; N. Jane Taylor; J. James Stirling; Linda Poupard; Lisa K. Folkes; Pei-san Chan; R. Barbara Pedley; Kerry A. Chester; Karen Owen; John A. Violet; Alessandra Malaroda; Alan J. Green; John Buscombe; Anwar R. Padhani; Gordon J. Rustin; Richard H. Begent
Combined Survival Analysis of Prospective Clinical Trials of Gefitinib for Non–Small Cell Lung Cancer with EGFR Mutations
Satoshi Morita; Isamu Okamoto; Kunihiko Kobayashi; Koichi Yamazaki; Hajime Asahina; Akira Inoue; Koichi Hagiwara; Noriaki Sunaga; Noriko Yanagitani; Toyoaki Hida; Kimihide Yoshida; Tomonori Hirashima; Kosei Yasumoto; Kenji Sugio; Tetsuya Mitsudomi; Masahiro Fukuoka; Toshihiro Nukiwa
Rapid Immune Recovery and Graft-versus-Host Disease–like Engraftment Syndrome following Adoptive Transfer of Costimulated Autologous T Cells
Aaron P. Rapoport; Edward A. Stadtmauer; Nicole Aqui; Dan Vogl; Anne Chew; Hong-Bin Fang; Stephen Janofsky; Kelly Yager; Elizabeth Veloso; Zhaohui Zheng; Todd Milliron; Sandra Westphal; Julio Cotte; Hong Huynh; Andrea Cannon; Saul Yanovich; Gorgun Akpek; Ming Tan; Kristen Virts; Kathleen Ruehle; Carolynn Harris; Sunita Philip; Robert H. Vonderheide; Bruce L. Levine; Carl H. June
Detection of KRAS Oncogene in Peripheral Blood as a Predictor of the Response to Cetuximab Plus Chemotherapy in Patients with Metastatic Colorectal Cancer
Li-Chen Yen; Yung-Sung Yeh; Chao-Wen Chen; Hwei-Ming Wang; Hsiang-Lin Tsai; Chien-Yu Lu; Yu-Tang Chang; Koung-Shing Chu; Shiu-Ru Lin; Jaw-Yuan Wang
Advertisement
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds